Compare RRX & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RRX | BIO |
|---|---|---|
| Founded | 1955 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7700 |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 8.2B |
| IPO Year | 1987 | N/A |
| Metric | RRX | BIO |
|---|---|---|
| Price | $144.72 | $303.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $169.80 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 762.2K | 155.9K |
| Earning Date | 02-04-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.96% | N/A |
| EPS Growth | ★ 22.48 | N/A |
| EPS | ★ 3.87 | N/A |
| Revenue | ★ $5,872,300,000.00 | $2,557,500,000.00 |
| Revenue This Year | N/A | $1.62 |
| Revenue Next Year | $3.79 | $2.26 |
| P/E Ratio | $37.53 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $90.56 | $211.43 |
| 52 Week High | $167.78 | $373.69 |
| Indicator | RRX | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 52.23 | 44.66 |
| Support Level | $139.41 | $298.78 |
| Resistance Level | $146.34 | $307.07 |
| Average True Range (ATR) | 4.79 | 7.77 |
| MACD | -0.38 | -0.88 |
| Stochastic Oscillator | 30.38 | 35.90 |
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The four operating segments include Commercial Systems, Industrial Systems, Climate Solutions, and Motion Control Solutions.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.